Endoscopic Valve Therapy in COPD Patients with Hypercapnia
暂无分享,去创建一个
F. Herth | R. Eberhardt | D. Gompelmann | K. Kriegsmann | M. Polke | K. Kontogianni | Nilab Polke | M. Roetting
[1] S. Makani,et al. Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial , 2019, American journal of respiratory and critical care medicine.
[2] F. Herth,et al. Interventional therapy in patients with severe emphysema: evaluation of contraindications and their incidence , 2019, Therapeutic advances in respiratory disease.
[3] A. Sung,et al. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE) , 2018, American journal of respiratory and critical care medicine.
[4] R. Eberhardt,et al. The minimal important difference for target lobe volume reduction after endoscopic valve therapy , 2018, International journal of chronic obstructive pulmonary disease.
[5] G. Hillerdal,et al. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM) , 2017, American journal of respiratory and critical care medicine.
[6] D. Slebos,et al. Improved Predictors of Survival after Endobronchial Valve Treatment in Patients with Severe Emphysema. , 2017, American journal of respiratory and critical care medicine.
[7] F. Herth,et al. Survival after Endoscopic Valve Therapy in Patients with Severe Emphysema , 2016, Respiration.
[8] E. V. van Rikxoort,et al. Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation. , 2015, The New England journal of medicine.
[9] D. Hansell,et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial , 2015, The Lancet.
[10] Stefano Nava,et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. , 2014, The Lancet. Respiratory medicine.
[11] M. Noppen,et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort , 2012, European Respiratory Journal.
[12] D. Hansell,et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD , 2010, European Respiratory Journal.
[13] J. Garrett,et al. Endoscopic lung volume reduction effectively treats acute respiratory failure secondary to bullous emphysema , 2010, Respirology.
[14] I. Kawase,et al. Severe bullous emphysema and hypercapnia successfully treated by bronchoscopic lung volume reduction , 2009, Respirology.
[15] P. Calverley,et al. Respiratory failure in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[16] W. Bailey,et al. Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.